Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business Sort descending
  • Functional Area
  • Date Posted
Job Title Site Location Division Business Sort descending Functional Area Date Posted
(高级)医药代表 /(资深)产品专员 Chuzhou (Anhui Province) China International Innovative Medicines Sales Jun 06, 2024
Lead/Associate, CX Content Creation Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 20, 2024
Specialist za analitiko v Centru za testiranje surovin (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 20, 2024
Clinical Label Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 20, 2024
Laboratorijski analitik v medfazni analitiki (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Quality Oct 20, 2024
Analyst - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Oct 21, 2024
Director of Patient-Centered Outcomes London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Oct 21, 2024
Expert - Medical Device Testing Laboratory (m/f/d) Schaftenau Austria Development Innovative Medicines Research & Development Oct 21, 2024
Sr. eCompliance Specialist Hyderabad (Office) India Operations Innovative Medicines Quality Oct 21, 2024
Finančni analitik poslovnega planiranja in analiz (m/ž/d) / BPA Finance Analyst (m/f/d) Ljubljana Slovenia Finance Innovative Medicines Audit & Finance Oct 21, 2024
Projektni kontroler (m/ž/d) / Project controller (m/f/d) Ljubljana Slovenia Operations Innovative Medicines Technical Operations Oct 21, 2024
Associate Clinical Label Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 21, 2024
Associate Supply Chain Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 21, 2024
Brand Manager Dublin (Country President Office (CPO)) Ireland International Innovative Medicines Marketing Oct 21, 2024
Quality Assurance Associate (Europe) Warsaw Poland Operations Innovative Medicines Quality Oct 21, 2024
Process Expert Saluggia Italy Operations Innovative Medicines Technical Operations Oct 21, 2024
Buyer Indianapolis USA Operations Innovative Medicines Procurement Oct 21, 2024
Director Data Science East Hanover USA US Innovative Medicines Data and Digital Oct 21, 2024
Senior Manager, New Product Planning Montreal Canada International Innovative Medicines Market Access Oct 21, 2024
Manager PSP Operations Montreal Canada International Innovative Medicines Marketing Oct 21, 2024
Business Excellence & Execution IM Head, Mexico INSURGENTES Mexico International Innovative Medicines Marketing Oct 21, 2024
Associate/Manager, MSL(Oncology) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Jul 22, 2024
Product Specialist Fuzhou (Fujian Province) China International Innovative Medicines Sales Jul 23, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Solution Design Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Sep 03, 2024
MR Fuyang (Anhui Province) China International Innovative Medicines Sales Aug 05, 2024
Senior/Advanced Medical/Sales Representative Beijing (Beijing) China International Innovative Medicines Sales Aug 06, 2024
Product Specialist Jingzhou (Hubei Province) China International Innovative Medicines Sales Aug 06, 2024
Associate/Manager, MSL (Cardiovascular) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Aug 20, 2024
Medical Field Trainer Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Aug 29, 2024
(高级)医药代表 /(资深)产品专员 Xianyang (Shanxi Province) China International Innovative Medicines Sales Aug 30, 2024
MR Beijing (Beijing) China International Innovative Medicines Sales Sep 01, 2024
Study Leader Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 05, 2024
Group Manager, MSL Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Sep 05, 2024
县域主任/县域主管 Yibin (Sichuan Province) China International Innovative Medicines Sales Sep 10, 2024
Japan Program Clinical Head (IMM) Head Office (Japan) (Pharmaceuticals) Japan Biomedical Research Innovative Medicines Research & Development Sep 10, 2024
MR Pingxiang (Jiangxi Province) China International Innovative Medicines Sales Sep 23, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)医药代表 /(资深)产品专员 Taiyuan (Shanxi Province) China International Innovative Medicines Sales Sep 24, 2024
县域主任(主管) Luoyang (Henan Province) China International Innovative Medicines Sales Sep 26, 2024
(高级)医药代表 /(资深)产品专员 Xian (Shanxi Province) China International Innovative Medicines Sales Sep 29, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
TA Strategy Lead - GenMed Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 02, 2024
CX strategy Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 04, 2024
TA Strategy Lead, RLT (Prostate Cancer) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 07, 2024
Lead, Integrated Insights & Planning_市場調査 Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 07, 2024
Associate, TA Medical (General Medicines) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Oct 07, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only